Prostate cancer likely affects 1 in 8 men during their lifetime. Those with family history of breast cancer in mothers or sisters, are also at increased risk. “In the curable stages, prostate cancer is not symptomatic. If you are waiting for symptoms, you are missing a window of opportunity,”says Dr Rajesh Gulia adding, “The American Cancer Society recommends testing for prostate cancer for men who are 50.” The traditional method for diagnosing cancer prostate is screening by serum prostate-specific antigen (PSA) or by digital rectal examination (DRE), followed by a 10–12 core transrectal ultrasonography (TRUS)-guided prostate biopsy. However, about 20% 30% of the cancers are missed by this approach.